Literature DB >> 12942185

[Alopecia areata. Clinical aspects, pathogenesis and rational therapy of a T-cell-induced autoimmune disease].

P Freyschmidt-Paul1, R Happle, R Hoffmann.   

Abstract

Alopecia areata is a T-cell mediated autoimmune disease directed against an unknown auto antigen of the hair follicle. There is a genetic predisposition to develop alopecia areata, whereas environmental triggers have so far not been identified. The diagnosis can be established by characteristic clinical features of alopecia areata including its severe forms alopecia areata totalis and universalis. Nail changes may help confirm the diagnosis. On rare occasions a histopathological examination may be necessary, whereas other laboratory investigations are unnecessary. Because of the high rate of spontaneous remission, the efficacy of a rational treatment of alopecia areata has to be proven in controlled studies and it should be associated with only minor side effects. According to the rules of evidence-based medicine, treatment with a contact sensitizer is at present the most effective treatment of alopecia areata showing only mild side effects. However, it is time-consuming and in some cases ineffective, making it desirable to develop new, more specific forms of treatment.

Entities:  

Mesh:

Year:  2003        PMID: 12942185     DOI: 10.1007/s00105-003-0560-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  45 in total

1.  Interleukin-10-deficient mice are less susceptible to the induction of alopecia areata.

Authors:  Pia Freyschmidt-Paul; Kevin J McElwee; Rudolf Happle; Sabine Kissling; Elke Wenzel; John P Sundberg; Margot Zöller; Rolf Hoffmann
Journal:  J Invest Dermatol       Date:  2002-10       Impact factor: 8.551

2.  Alopecia areata but not androgenetic alopecia is characterized by a restricted and oligoclonal T-cell receptor-repertoire among infiltrating lymphocytes.

Authors:  D Dressel; C H Brütt; B Manfras; T M Zollner; A Wunderlich; B O Böhm; W H Boehncke
Journal:  J Cutan Pathol       Date:  1997-03       Impact factor: 1.587

3.  Treatment of alopecia areata with steroid solution.

Authors:  J L Leyden; A M Kligman
Journal:  Arch Dermatol       Date:  1972-12

4.  Alopecia areata: alterations in the hair growth cycle and correlation with the follicular pathology.

Authors:  A G Messenger; D N Slater; S S Bleehen
Journal:  Br J Dermatol       Date:  1986-03       Impact factor: 9.302

5.  Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice.

Authors:  Pia Freyschmidt-Paul; Kevin J McElwee; Vladimir Botchkarev; Sabine Kissling; Elke Wenzel; John P Sundberg; Rudolf Happle; Rolf Hoffmann
Journal:  J Investig Dermatol Symp Proc       Date:  2003-06

6.  Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.

Authors:  Desmond J Tobin; Sarah H Gardner; Nigel J Lindsey; Rolf Hoffmann; Rudolf Happle; Pia Freyschmidt-Paul
Journal:  Eur J Dermatol       Date:  2002 Jul-Aug       Impact factor: 3.328

7.  Cell degeneration in alopecia areata. An ultrastructural study.

Authors:  D J Tobin; D A Fenton; M D Kendall
Journal:  Am J Dermatopathol       Date:  1991-06       Impact factor: 1.533

8.  Expression of classical and non-classical MHC class I antigens in murine hair follicles.

Authors:  R Paus; S Eichmüller; U Hofmann; B M Czarnetzki; P Robinson
Journal:  Br J Dermatol       Date:  1994-08       Impact factor: 9.302

9.  Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene.

Authors:  J K Tarlow; F E Clay; M J Cork; A I Blakemore; A J McDonagh; A G Messenger; G W Duff
Journal:  J Invest Dermatol       Date:  1994-09       Impact factor: 8.551

10.  Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata.

Authors:  Margot Zöller; Kevin J McElwee; Peter Engel; Rolf Hoffmann
Journal:  J Invest Dermatol       Date:  2002-06       Impact factor: 8.551

View more
  4 in total

1.  [Alopecia areata].

Authors:  V von Felbert; H F Merk
Journal:  Hautarzt       Date:  2013-11       Impact factor: 0.751

2.  [Associated diseases and differential diagnostic considerations in childhood atopic eczema].

Authors:  C Jenneck; R Foelster-Holst; T Hagemann; N Novak
Journal:  Hautarzt       Date:  2007-02       Impact factor: 0.751

Review 3.  The Diagnosis and Treatment of Hair and Scalp Diseases.

Authors:  Hans Wolff; Tobias W Fischer; Ulrike Blume-Peytavi
Journal:  Dtsch Arztebl Int       Date:  2016-05-27       Impact factor: 5.594

4.  [Drug treatment of alopecia].

Authors:  H Wolff
Journal:  Internist (Berl)       Date:  2015-10       Impact factor: 0.743

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.